|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1101 to 1200 out of 3733 for Mak

<< First    < Previous  |  Next >    Last >>
0.023s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication
15187144 | J:90821
First Author: Bancroft AJ
Year: 2004
Journal: J Immunol
Title: WSX-1: a key role in induction of chronic intestinal nematode infection.
Volume: 172
Issue: 12
Pages: 7635-41
•
•
•
•
•
Publication
19596985 | J:151585
First Author: Troy AE
Year: 2009
Journal: J Immunol
Title: IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.
Volume: 183
Issue: 3
Pages: 2037-44
•
•
•
•
•
Publication
24101691 | J:205996
First Author: Gwyer Findlay E
Year: 2014
Journal: Infect Immun
Title: IL-27 receptor signaling regulates memory CD4+ T cell populations and suppresses rapid inflammatory responses during secondary malaria infection.
Volume: 82
Issue: 1
Pages: 10-20
•
•
•
•
•
Publication
26260044 | J:233396
First Author: Flores RR
Year: 2015
Journal: Eur J Immunol
Title: IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice.
Volume: 45
Issue: 11
Pages: 3114-25
•
•
•
•
•
Publication
24244314 | J:209311
First Author: Villegas-Mendez A
Year: 2013
Journal: PLoS One
Title: WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways.
Volume: 8
Issue: 11
Pages: e78486
•
•
•
•
•
Publication
35354611 | J:325673
First Author: Sharma A
Year: 2022
Journal: J Immunol
Title: IL-27 Enhances γδ T Cell-Mediated Innate Resistance to Primary Hookworm Infection in the Lungs.
Volume: 208
Issue: 8
Pages: 2008-2018
•
•
•
•
•
Publication
17982030 | J:153872
First Author: Wang S
Year: 2007
Journal: J Immunol
Title: Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency.
Volume: 179
Issue: 10
Pages: 6421-8
•
•
•
•
•
Publication
17403877 | J:121923
First Author: Shainheit MG
Year: 2007
Journal: Infect Immun
Title: Disruption of interleukin-27 signaling results in impaired gamma interferon production but does not significantly affect immunopathology in murine schistosome infection.
Volume: 75
Issue: 6
Pages: 3169-77
•
•
•
•
•
Publication
21925473 | J:177366
First Author: Fujimoto H
Year: 2011
Journal: Am J Pathol
Title: IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice.
Volume: 179
Issue: 5
Pages: 2327-36
•
•
•
•
•
Publication
38390338 | J:350746
 
First Author: Bradford SD
Year: 2024
Journal: Front Immunol
Title: IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model.
Volume: 15
Pages: 1217098
•
•
•
•
•
Publication
36891292 | J:343716
 
First Author: Povroznik JM
Year: 2023
Journal: Front Immunol
Title: Interleukin-27-dependent transcriptome signatures during neonatal sepsis.
Volume: 14
Pages: 1124140
•
•
•
•
•
Publication
32292786 | J:291500
 
First Author: Hu A
Year: 2020
Journal: Front Cell Dev Biol
Title: Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy.
Volume: 8
Pages: 210
•
•
•
•
•
Publication
15067040 | J:89112
First Author: Artis D
Year: 2004
Journal: J Immunol
Title: Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.
Volume: 172
Issue: 8
Pages: 4672-5
•
•
•
•
•
Publication
34691022 | J:312718
 
First Author: Huang D
Year: 2021
Journal: Front Immunol
Title: IL-27 Mediates Pro-Inflammatory Effects via the ERK Signaling Pathway During Preterm Labor.
Volume: 12
Pages: 709229
•
•
•
•
•
Publication
32305041 | J:301309
First Author: He H
Year: 2020
Journal: Blood
Title: Aging-induced IL27Ra signaling impairs hematopoietic stem cells.
Volume: 136
Issue: 2
Pages: 183-198
•
•
•
•
•
Publication
17118967 | J:116610
First Author: Sonoda KH
Year: 2007
Journal: Int Immunol
Title: WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis.
Volume: 19
Issue: 1
Pages: 93-8
•
•
•
•
•
Strain
MGI:6159267 | B6.129P2-Birc5<tm1Mak>/J
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5701676 | B6.129P2-Cycs<tm1Mak>/Cnbc
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5701692 | B6;129P2-Cycs<tm1Mak>/Cnbc
Attribute String: targeted mutation, mutant stock
•
•
•
•
•
Allele
Hipk1<tm1Mak> | MGI:3584135
Name: homeodomain interacting protein kinase 1; targeted mutation 1, Tak Wah Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Allele
Rhoc<tm1Mak> | MGI:3589206
Name: ras homolog family member C; targeted mutation 1, Tak W Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:5562345 | B6.129P2-Lcn2<tm1Mak>/Cnbc
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Publication
24721803 | J:318190
First Author: Song E
Year: 2014
Journal: J Am Heart Assoc
Title: Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice.
Volume: 3
Issue: 2
Pages: e000837
•
•
•
•
•
Publication
26595644 | J:309230
First Author: Ashraf MI
Year: 2016
Journal: Am J Transplant
Title: Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation.
Volume: 16
Issue: 3
Pages: 808-20
•
•
•
•
•
Publication
37240031 | J:355749
 
First Author: Müller N
Year: 2023
Journal: Int J Mol Sci
Title: Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury.
Volume: 24
Issue: 10
•
•
•
•
•
Publication
30615971 | J:295046
 
First Author: Borkham-Kamphorst E
Year: 2019
Journal: Cell Signal
Title: Liver parenchymal cells lacking Lipocalin 2 (LCN2) are prone to endoplasmic reticulum stress and unfolded protein response.
Volume: 55
Pages: 90-99
•
•
•
•
•
Publication
34518636 | J:329811
First Author: Borkham-Kamphorst E
Year: 2021
Journal: Lab Invest
Title: Chronic mineral oil administration increases hepatic inflammation in wild type mice compared to lipocalin 2 null mice.
Volume: 101
Issue: 12
Pages: 1528-1539
•
•
•
•
•
Publication
34884961 | J:329479
 
First Author: Klüber P
Year: 2021
Journal: Int J Mol Sci
Title: Depletion of Lipocalin 2 (LCN2) in Mice Leads to Dysbiosis and Persistent Colonization with Segmented Filamentous Bacteria.
Volume: 22
Issue: 23
•
•
•
•
•
Publication
23701109 | J:329502
First Author: Sickinger S
Year: 2013
Journal: Transpl Int
Title: Lipocalin-2 as mediator of chemokine expression and granulocyte infiltration during ischemia and reperfusion.
Volume: 26
Issue: 7
Pages: 761-9
•
•
•
•
•
Publication
34903175 | J:329482
First Author: Wu D
Year: 2021
Journal: BMC Genomics
Title: The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model.
Volume: 22
Issue: 1
Pages: 892
•
•
•
•
•
Publication
35856297 | J:329843
First Author: Gasterich N
Year: 2022
Journal: Glia
Title: Lipocalin 2 attenuates oligodendrocyte loss and immune cell infiltration in mouse models for multiple sclerosis.
Volume: 70
Issue: 11
Pages: 2188-2206
•
•
•
•
•
Publication
31722218 | J:295433
First Author: Yammine L
Year: 2019
Journal: Cell Rep
Title: Lipocalin-2 Regulates Epidermal Growth Factor Receptor Intracellular Trafficking.
Volume: 29
Issue: 7
Pages: 2067-2077.e6
•
•
•
•
•
Publication
34224151 | J:329812
First Author: Ponzetti M
Year: 2022
Journal: J Cell Physiol
Title: Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice.
Volume: 237
Issue: 1
Pages: 551-565
•
•
•
•
•
Publication
37871404 | J:342373
 
First Author: Saenz-Pipaon G
Year: 2023
Journal: Atherosclerosis
Title: Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P.
Volume: 385
Pages: 117343
•
•
•
•
•
Publication
22075378 | J:181040
First Author: Rodvold JJ
Year: 2012
Journal: Cancer Lett
Title: Lipocalin 2 in cancer: when good immunity goes bad.
Volume: 316
Issue: 2
Pages: 132-8
•
•
•
•
•
Publication
28396494 | J:242011
First Author: Cramer EP
Year: 2017
Journal: Blood
Title: Lipocalin-2 from both myeloid cells and the epithelium combats Klebsiella pneumoniae lung infection in mice.
Volume: 129
Issue: 20
Pages: 2813-2817
•
•
•
•
•
Allele
Vtcn1<tm1Mak> | MGI:3663315
Name: V-set domain containing T cell activation inhibitor 1; targeted mutation 1, Tak W Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:5788576 | B6.129P2(Cg)-Tradd<tm1.1Mak>/J
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
28013046 | J:251597
First Author: Wu L
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Volume: 483
Issue: 2
Pages: 810-815
•
•
•
•
•
Strain
MGI:6276223 | B6.129P2-Trp73<tm1Mak>
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Strain
MGI:7380533 | B6.129-Trp73<tm1Mak>
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:6143649 | B6.129P2-Trp73<tm1Mak>/Mmmh
Attribute String: mutant strain, congenic, targeted mutation
•
•
•
•
•
Strain
MGI:7571050 | B6.129P2-Trp73<tm1Mak>/H
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Publication
27119504 | J:309647
First Author: Agostini M
Year: 2016
Journal: Oncotarget
Title: Metabolic pathways regulated by TAp73 in response to oxidative stress.
Volume: 7
Issue: 21
Pages: 29881-900
•
•
•
•
•
Strain
MGI:5638894 | B6.129P2-Trp73<tm2Mak>/Mmmh
Attribute String: mutant strain, congenic, targeted mutation
•
•
•
•
•
Strain
MGI:7570996 | B6.129P2-Trp73<tm2Mak>/H
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:4442927 | B6.129P2-Trp73<tm2Mak>
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5657233 | either: B6.129P2-Trp73<tm2Mak> or (involves: 129P2/OlaHsd * C57BL/6J)
Attribute String: Not specified
•
•
•
•
•
Strain
MGI:4460228 | B6.129P2-Trim3<tm1Mak>
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5701696 | B6.129P2-Trim3<tm1Mak>/Cnbc
Attribute String: mutant strain, targeted mutation, congenic
•
•
•
•
•
Allele
Anp32e<tm1Mak> | MGI:4867888
Name: acidic nuclear phosphoprotein 32 family member E; targeted mutation 1, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Allele
Anp32a<tm1Mak> | MGI:4949091
Name: acidic nuclear phosphoprotein 32 family member A; targeted mutation 1, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Allele
Anp32b<tm1Mak> | MGI:5003050
Name: acidic nuclear phosphoprotein 32 family member B; targeted mutation 1, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:5295176 | B6.Cg-Tslp<tm1Mak>
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Strain
MGI:5309155 | B6.129P2-Rhbdf2<tm1Mak>
Attribute String: mutant strain, targeted mutation, congenic
•
•
•
•
•
Strain
MGI:6198335 | B6.129P2-Rhbdf2<tm1Mak>/Mmjax
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
32135161 | J:291967
 
First Author: Skurski J
Year: 2020
Journal: Metabolism
Title: Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation.
Volume: 106
Pages: 154194
•
•
•
•
•
Allele
Huwe1<tm1.1Mak> | MGI:5314816
Name: HECT, UBA and WWE domain containing 1; targeted mutation 1.1, Tak Mak
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
•
•
•
•
•
Allele
Huwe1<tm1.2Mak> | MGI:5314817
Name: HECT, UBA and WWE domain containing 1; targeted mutation 1.2, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Allele
Arih2<tm1Mak> | MGI:5463664
Name: ariadne RBR E3 ubiquitin protein ligase 2; targeted mutation 1, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:5496848 | B6.129S2-Fcmr<tm1Mak>
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Strain
MGI:5701707 | B6.129P2-Bag6<tm1Mak>/Cnbc
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5789010 | B6.129P2-Akna<tm1Mak>
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Strain
MGI:5788728 | B6.129P2-Akna<tm1Mak>/J
Attribute String: congenic, mutant strain, targeted mutation
•
•
•
•
•
Allele
Arhgef11<tm1.1Mak> | MGI:5788572
Name: Rho guanine nucleotide exchange factor 11; targeted mutation 1.1, Tak Mak
Allele Type: Targeted
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:5789012 | B6.129-Akna<tm2Mak>
Attribute String: targeted mutation, mutant strain, congenic
•
•
•
•
•
Allele
Arhgef11<tm1Mak> | MGI:6110837
Name: Rho guanine nucleotide exchange factor 11; targeted mutation 1, Tak Mak
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
•
•
•
•
•
Allele
Acvr1<tm1Mak> | MGI:6414907
Name: activin A receptor, type 1; targeted mutation 1, Tak W Mak
Allele Type: Targeted
Attribute String: Conditional ready
•
•
•
•
•
Allele
Acvr1<tm1.1Mak> | MGI:6414911
Name: activin A receptor, type 1; targeted mutation 1.1, Tak W Mak
Allele Type: Targeted
Attribute String: Conditional ready
•
•
•
•
•
Genotype
Genotype
Symbol: Traf6/Traf6
Background: involves: 129P3/J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Traf2/Traf2
Background: involves: 129P2/OlaHsd * BALB/c * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Traf2/Traf2
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Traf2/Traf2
Background: either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Chek2/Chek2
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Icos/Icos
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Icosl/Icosl
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Diablo/Diablo
Background: involves: 129P2/OlaHsd
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cd8a/Cd8a
Background: involves: 129S2/SvPas * C57BL/6 * DBA/2
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cd8a/Cd8a
Background: PL.129S2(B6)-Cd8a/Rdgz
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cd8a/Cd8a
Background: SJL.129S2(B6)-Cd8a/Rdgz
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Tsg101/Tsg101
Background: either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Msh2/Msh2
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca1/Brca1
Background: either: (involves: 129P2/OlaHsd * C3H/HeJ) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Smad4/Smad4
Background: either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * C57BL/6J * CD-1)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cycs/Cycs
Background: involves: C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Irf4/Irf4
Background: involves: 129P2/OlaHsd
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Irf4/Irf4
Background: B6.129P2-Irf4
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Irf4/Irf4
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Casp9/Casp9
Background: either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Birc5/Birc5
Background: involves: 129P2/OlaHsd
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Lcn2/Lcn2
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Casp3/Casp3
Background: B6.129P2-Casp3
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Irf2/Irf2
Background: involves: 129S2/SvPas * C57BL/6
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Bcl10/Bcl10
Background: involves: 129P2/OlaHsd
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cd44/Cd44
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gnpnat1/Gnpnat1
Background: either: (involves: C57BL/6J) or (involves: CD-1)
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Itgal/Itgal
Background: B6.129P2-Itgal
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Il2rb/Il2rb
Background: B6.129-Il2rb
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Il2rb/Il2rb
Background: C.129-Il2rb
Zygosity: hm
Has Mutant Allele: true
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom